In today’s episode of the podcast, I interview Dr. Rocio Salas-Whalen, owner of New York Endocrinology on Park Avenue. Dr. Salas-Whalen has deep expertise in diabetes, metabolism, obesity, thyroid abnormalities and other endocrine disorders. She completed her internal medicine residency at Albert Einstein College of Medicine and her endocrinology fellowship at the University of Maryland School of Medicine in Baltimore. Additionally, she was a research fellow at Johns Hopkins University School of Medicine and is board certified in Obesity Medicine.
We will be discussing obesity and weight loss. The definition of obesity has changed significantly in the last few years. In 1942, WHO classified obesity as a chronic disease. In 2013, the American Medical Association accepted it as a chronic metabolic and multifactorial disease.
There are no conflicts of interest for this episode.
Medications mentioned:
GLP-1 Wegovy (semaglutide) (weekly injection)
GLP-1 Saxenda (liraglutide) (daily injection)
GLP-1 & GIP, Mounjaro (tirzepatide) (weekly injection) (only FDA approved for diabetes)
Qsymia (a combination of phentermine/topiramate)
Link to Full Blog: www.psychiatrypodcast.com/psy...
Негізгі бет Ғылым және технология Weight Loss with Dr. Rocio Salas-Whalen: GLP-1 Wegovy (semaglutide) and Mounjaro (Tirzepatide)
Пікірлер: 1